Isentress (Raltegravir)

Raltegravir · Merck & Co.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Isentress (Raltegravir), covering 2012-10-16 to 2024-06-18. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetics Distribution of Raltegravir by PET/MR [EARLY_Phase 1]